Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Lightspeed Commerce
LSPD
$1.42B
| $22M | 0.03% |
228,100
+150,000
| +192% | +$14.9M |
|
627
PetMed Express
PETS
$43.4M
| $22M | 0.03% |
819,169
-53,904
| -6% | -$1.55M |
|
|
AY
628
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $22M | 0.03% |
637,455
| – | – |
|
629
MasTec
MTZ
$23B
| $22M | 0.03% |
254,700
+44,600
| +21% | +$4.23M |
|
|
BAND
630
Bandwidth Inc
BAND
$1.74B
| $21.9M | 0.03% |
243,100
+135,900
| +127% | +$15.7M |
|
631
Varonis Systems
VRNS
$5.26B
| $21.9M | 0.03% |
359,900
-212,000
| -37% | -$13.3M |
|
632
Paycom
PAYC
$10.1B
| $21.9M | 0.03% |
44,150
-15,100
| -25% | -$6.73M |
|
633
Kohl's
KSS
$2.22B
| $21.9M | 0.03% |
464,300
+18,200
| +4% | +$973K |
|
634
Atlanta Braves Holdings Series B
BATRK
$3.41B
| $21.8M | 0.03% |
826,719
-10,000
| -1% | -$263K |
|
635
Banco Santander Chile
BSAC
$16.1B
| $21.8M | 0.03% |
1,102,127
-158,400
| -13% | -$3.12M |
|
|
ONEM
636
DELISTED
1Life Healthcare
ONEM
| $21.8M | 0.03% |
1,074,900
+327,700
| +44% | +$8.42M |
|
637
Weis Markets
WMK
$1.77B
| $21.7M | 0.03% |
413,136
| – | – |
|
638
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $21.7M | 0.03% |
116,083
-14,100
| -11% | -$2.55M |
|
639
Texas Roadhouse
TXRH
$13.6B
| $21.7M | 0.03% |
237,672
-7,634
| -3% | -$712K |
|
640
Gevo
GEVO
$401M
| $21.7M | 0.03% |
3,266,800
-853,700
| -21% | -$5.28M |
|
641
Safe Bulkers
SB
$781M
| $21.6M | 0.03% |
4,178,486
-1,314,984
| -24% | -$5.08M |
|
|
SPTN
642
DELISTED
SpartanNash
SPTN
| $21.6M | 0.03% |
985,612
-10,503
| -1% | -$211K |
|
643
Argan
AGX
$7.84B
| $21.6M | 0.03% |
494,096
-2,503
| -0.5% | -$113K |
|
644
ICU Medical
ICUI
$4.58B
| $21.6M | 0.03% |
92,400
+37,100
| +67% | +$7.78M |
|
|
CNBKA
645
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $21.5M | 0.03% |
186,957
+10,535
| +6% | +$1.21M |
|
646
Red Rock Resorts
RRR
$3.67B
| $21.5M | 0.03% |
420,500
+273,500
| +186% | +$11.9M |
|
647
Ovintiv
OVV
$17.2B
| $21.4M | 0.03% |
651,188
-181,300
| -22% | -$5.01M |
|
|
SPNS
648
DELISTED
Sapiens International
SPNS
| $21.4M | 0.03% |
743,203
-94,900
| -11% | -$2.6M |
|
649
Endava
DAVA
$167M
| $21.4M | 0.03% |
157,263
+85,600
| +119% | +$11.1M |
|
650
Utah Medical Products
UTMD
$230M
| $21.4M | 0.03% |
230,035
-13,879
| -6% | -$1.23M |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.